1-7 of 7
Linna Xie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective Study of Rituximab/Bendamustine and Rituximab/DHAP +/- Zanubrutinib Induction Therapy with or without ASCT in Young Newly Diagnosed Mantle Cell Lymphoma

Hui Wang, Lijie Xing, Dan Liu, Haichen Wei, Ke Lu, Qiang He, Linna Xie, Ji Ma, Lugui Qiu, Zengjun Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 6307.
https://doi.org/10.1182/blood-2024-206243
Published: 2024
Journal Articles

Uncovering Therapeutic Resistance in BPDCN through Single-Cell Transcriptome Profiling

Ji Ma, Qiang He, Qian Wu, Lili Feng, Y. Lynn Wang, Linna Xie
Journal: Blood
Blood (2024) 144 (Supplement 1): 1557.
https://doi.org/10.1182/blood-2024-204227
Published: 2024
Journal Articles

Safety and Efficacy in Patients with Advanced Lymphomas from a Global Phase 1a/1b, First-in-Human Study of CS5001, a Novel Anti-ROR1 ADC

Yuqin Song, Jian Zhang, Keshu Zhou, Liling Zhang, Minal Barve, Charlotte Lemech, Wenyu Li, Hua-Jay J. Cherng, He Huang, Linna Xie, Richard Zuniga, Caicun Zhou, Lin Shen, Shujun Yang, Sarwan Bishnoi, Yan Zhang, Jingru Wang, Xiaoli Zhu, Fei Li, Jason Yang
Journal: Blood
Blood (2024) 144 (Supplement 1): 1739.
https://doi.org/10.1182/blood-2024-192979
Published: 2024
Journal Articles

Health-Related Quality of Life (HRQL) in Cutaneous T-Cell Lymphoma: Psychological Burden and Influencing Factors from Mycosis Fungoides and Sézary Syndrome Patients in China

Tun-Ying Hsu, Huiping Sun, Zhiming Li, Wenrong Huang, Linna Xie, Xiaojing Yan, Haifeng Zhao, Ki Hyon Kim, Yuankai Shi
Journal: Blood
Blood (2023) 142 (Supplement 1): 7354.
https://doi.org/10.1182/blood-2023-179638
Published: 2023
Journal Articles

Methotrexate in Combination with Orelabrutinib, Thiotepa, and Rituximab (R-MTO) Followed By Autologous Stem-Cell Transplant for Primary Central Nervous System Lymphoma Treatment

Lijie Xing, Haichen Wei, Dan Liu, Hui Wang, Ping Li, Linna Xie, Zengjun Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6228.
https://doi.org/10.1182/blood-2023-186219
Published: 2023
Journal Articles

Interim Report of Bendamustine Plus Rituximab As First-Line Induction Therapy with or without Lenalidomide Maintenance Therapy in Chinese Patients with Indolent Non-Hodgkin's Lymphoma or Elderly Mantle Cell Lymphoma: Data from a Multi-Center Prospective Trial

Hui Wang, Qiang He, Rongrong Zhao, Linna Xie, Ji Ma, Cong Liu, Ke Lu, Haichen Wei, Dan Liu, Lijie Xing, Xiuzhi Deng, Zhongliang Sun, Xiaoxia Chu, Na Gao, Yuping Zhong, Yanhua Sun, Haiyan Zhang, Hao Zhang, Wenwei Xu, Zengjun Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 11962–11963.
https://doi.org/10.1182/blood-2022-162507
Published: 2022
Journal Articles

Zanubrutinib PLUS RCHOP(ZR-CHOP) Regimen Achieves High Complete Response Rate in the Treatment of Newly-Diagnosed Double-Expression Diffuse Large B Cell Lymphoma

Qiang He, Linna Xie, Rongrong Zhao, Ji Ma, Hui Wang, Jie Li, Chuanli Zhao, Y. Lynn Wang, Zengjun Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 6614–6615.
https://doi.org/10.1182/blood-2022-168859
Published: 2022